Medartis Holding AG (MED.SW)
Medartis Holding AG operates in the Medical - Devices industry of the Healthcare sector, headquartered in Basel, BS, CH. The stock last traded at $86.90, up 2.24% on the session, giving a market capitalisation of $1.08B. Its beta of 1.17 implies it has historically moved more than the broad market.
Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex cranio-maxillofacial surgical needs. The company's portfolio features osteosynthesis instruments, marketed under the APTUS and MODUS brands, specifically designed for various body regions including the hand, wrist, elbow, shoulder, foot, and ankle, as well as for facial and skull procedures involving the mandible, midface, orthognathic structures, and cranium. Medartis serves a diverse clientele comprising surgeons, hospitals, medical centers, and group purchasing organizations. The company, founded in 1997, is headquartered in Basel, Switzerland.
Medartis Holding AG is most often compared with the following Healthcare names: